Freeze-dried heat-resistant protective agent for porcine pseudorabies live vaccine, its preparation method and use
A technology for porcine pseudorabies and heat-resistant protective agent, applied in the field of immunity, can solve the problems of intolerance of porcine pseudorabies vaccine to freezing, heat intolerance of transportation and storage, etc., to solve the problem of low temperature cold chain, solve the problem of intolerance, Minimal loss of antigen
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Embodiment 1 Porcine pseudorabies live vaccine antigen preparation and the preparation of Hanks (containing phenol red)
[0039] Virus strain: PRV-Bartha-k61; cells: porcine testis cells (ST), all provided by the National Veterinary Biological Products Engineering Technology Research Center. Take a sample of porcine pseudorabies virus, dilute it 100 times with 2% DMEM, inoculate ST cells, culture at 37°C for 48 hours, harvest the virus liquid, freeze and thaw twice, filter with gauze, harvest the supernatant, and store the sample in Freeze at -80°C. After being tested for sterility, the virus content was determined to be 10 8.0 TCID 50 / ml, it can be used for seedling matching.
[0040] Preparation of Hanks (containing phenol red)
[0041] Hanks solution is the most commonly used inorganic salt solution and balanced salt solution (Balanced Salt Solutions, BSS) in biomedical experiments. Its preparation method is as follows:
[0042] stock solution A
[0043]
...
Embodiment 2
[0052] The mensuration of embodiment 2 heat-resistant protective agent thermal parameters
[0053] In order to better set the freeze-drying curve, the inventors measured the collapse temperature of the heat-resistant protective agent. The collapse temperature was determined by a low-temperature freeze-drying microscope, and the detection conditions were: Temp-40°C, Vac 20.0Pa, Ramp Row 3Rate 3°C / min, Limit-40°C. Specifically, it is tested by Shanghai Tofflon Co., Ltd. The test result is: protective agent -15°C.
Embodiment 3
[0054] The preparation of embodiment 3 protective agent 1 and the lyophilization of vaccine
[0055] The freeze-dried heat-resistant protective agent 1 is composed of the following components by weight percentage: 5% sucrose, 4% isomaltulose, 2% D-sorbitol, 1.5% glycerin, 3% hypromellose, 2.5% methionine, poly Poly D-lysine 0.01%, Hanks (containing phenol red), double pure water to make up to 100%.
[0056] Take the heat-resistant protective agent 1 and the qualified PRV-Bartha-k61 antigen at a volume of 1:1, mix them into 7ml vials, 2ml / bottle, and put the product half-stoppered with a butyl tripod stopper into a freeze-drying box Pre-cool the body at 4°C for 45 minutes, lower the temperature to -40°C at a rate of 1.37°C / min, and maintain the vaccine for 4-5 hours to freeze the vaccine. After vacuuming to 500mTorr, gradually increase the temperature at a rate of 1.87°C / min up to 6°C, maintain at this temperature for 2 hours, then cool down to -22°C at a rate of 2.2°C / min and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com